Cardiovascular non-Adherence Tailored Intervention (CATI) care programme
- Conditions
- Cardiovascular medication non-adherence
- Registration Number
- NL-OMON26090
- Lead Sponsor
- VU University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 176
Inclusion Criteria
1) Age 45-75 years
2) Using cardiovascular medication i.e. antihypertensive and/or lipid-lowering drugs
Exclusion Criteria
1) Being unable to speak or read Dutch
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-reported medication adherence is the primary outcome measure. Medication adherence will be assessed at baseline, at follow-up and at endline. Differences between the medication non-adherence at baseline and at endline will be compared. Medication adherence will be assessed with the MARS-5 questionnaire.
- Secondary Outcome Measures
Name Time Method DL concentration and BP are clinical secondary outcome measures. The pre-measurement will be included in the selection procedure at baseline and the post-measurement will be assessed after six months. LDL concentration will be measured with a finger prick of blood. Blood pressure will be measured with a sphygmomanometer. <br /><br><br /><br>Quality of life will be assessed by using the Short Form 12 Health Survey (SF-12) questionnaire. The SF-12 questionnaire consists of 12 questions covering eight dimension of health i.e. general health perception, physical functioning, limitations due to physical health problems, bodily pain, vitality, social functioning, emotional functioning and general mental health. The eight domains can produce two summary scores for physical health (Physical Component Score, PCS) and mental health (Mental Component Score, MCS).<br>